Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: The Wnt-β-catenin pathway promotes an insulin-sensitized state via up-regulation of its target gene, 21/January/2017, 7.50 am

Therapeutic insights into “awakening the sleeping/cancer-protecting angels” in mutant p53-expressing human tumors: Bergamottin (BGM), a natural Furanocoumarin found in grapefruit juice, increases the expression of tumor suppressor p53 homologue TA-p73/p63, PTEN, TPM1, TIMP3, BTG2, PDCD4, SPRY1/2 and CCM1/KRIT1 and induces regression of p53-mutated human tumors via down regulation of its target gene, 20/January/2017, 11.13 pm
January 20, 2017
Molecular therapy for Myocardial Infarction: Exenatide (brand name: Byetta, & Bydureon), a hypoglycemic agent that functions as a glucagon-like peptide-1 agonist (GLP-1 agonist), inhibits DNA damage responses, increases telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 21/January/2017, 2.10 pm
January 21, 2017
Show all

Introduction: What they say

A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates glucose metabolism.” This study was published in the 30 September  2011 issue of the Journal “Cell” [One of the best journals in Biological sciences with an I.F of 28.71]  by Prof Daley GQ, Zhu H, and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: The Wnt-β-catenin pathway promotes an insulin-sensitized state via up-regulation of  its target gene


Significance

Given that (1)  more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) the life-long painful injection/drug treatment is required to treat DM; and (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find a way to induce regeneration of adult β-cells that were lost in DM.


What is known?

Prof. Daley GQ and his team members had shown earlier that loss of Lin28 in muscles promotes insulin resistance and glucose intolerance. 


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, that the Wnt-β-catenin pathway, by increasing the expression of its target geneit may (1) increase the expression of IGF1R, INSR,and IRS2; (2) enhance tissue repair; (3) promote youthful regenerative capacity; and (4) promote insulin sensitivity. Thus, pharmacological formulations encompassing “Wnt-β-catenin pathway  activators” may be used to treat DM.

price-50


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $ 50

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Wnt-β-catenin pathway promote insulin-sensitized state?

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan L, Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: The Wnt-β-catenin pathway promotes an insulin-sensitized state via up-regulation of its target gene, 21/January/2017, 7.50 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.